title: Therapeutic considerations in the treatment of obesity hypertension.
abstract: Obesity, now recognized as an independent risk factor for cardiovascular disease, is closely associated with hypertension. Complex mechanisms link increasing body weight with increasing blood pressure. Treatment of the obese patient with hypertension requires consideration of physiologic changes related to obesity hypertension. Lifestyle modification, including weight reduction and increased physical activity, can directly influence blood pressure levels and improve blood pressure control in obese, hypertensive patients. Clinical trials are needed to determine the most effective antihypertensive drugs for the obese, hypertensive patient. Antiobesity drugs offer viable adjunctive pharmacotherapy for obesity hypertension, but additional long-term studies are needed to support their safety and efficacy.
authors.affiliation: Division of Hypertension, Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39216-4505, USA. mwofford@medicine.umsmed.edu
authors.forename: M R
authors.initials: MR
authors.lastname: Wofford
authors.forename: M M
authors.initials: MM
authors.lastname: Davis
authors.forename: K G
authors.initials: KG
authors.lastname: Harkins
authors.forename: D S
authors.initials: DS
authors.lastname: King
authors.forename: S B
authors.initials: SB
authors.lastname: Wyatt
authors.forename: D W
authors.initials: DW
authors.lastname: Jones
mesh_terms: D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D015897:Comorbidity; D018752:Diet, Fat-Restricted; D015444:Exercise; D005260:Female; D006801:Humans; D006973:Hypertension / Q000453:epidemiology* / Q000628:therapy*; D015994:Incidence; D008019:Life Style; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000453:epidemiology* / Q000628:therapy*; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents